Holen Sie sich die Stockscreener-App
145.17
0.28%
0.40
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt DVA?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$144.77
Offen:
$144.68
24-Stunden-Volumen:
524.01K
Relative Volume:
0.66
Marktkapitalisierung:
$10.96B
Einnahmen:
$12.82B
Nettoeinkommen (Verlust:
$936.34M
KGV:
13.52
EPS:
10.74
Netto-Cashflow:
$1.47B
1W Leistung:
+2.84%
1M Leistung:
+3.43%
6M Leistung:
-14.75%
1J Leistung:
+1.87%
1-Tages-Spanne:
$142.88
$145.21
1-Wochen-Bereich:
$138.65
$151.85
52-Wochen-Spanne:
$131.76
$179.60
Davita Inc Stock (DVA) Company Profile
Firmenname
Davita Inc
Sektor
Branche
Telefon
310-536-2668
Adresse
2000 16TH STREET, DENVER, CO
Vergleichen Sie DVA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
DVA
Davita Inc
|
145.17 | 10.94B | 12.82B | 936.34M | 1.47B | 10.74 |
|
HCA
Hca Healthcare Inc
|
334.32 | 82.15B | 71.59B | 5.78B | 4.95B | 22.49 |
|
FMS
Fresenius Medical Care Ag Adr
|
26.43 | 15.70B | 20.92B | 666.06M | 1.85B | 1.1422 |
|
THC
Tenet Healthcare Corp
|
153.02 | 13.78B | 20.52B | 1.46B | 1.41B | 15.12 |
|
EHC
Encompass Health Corp
|
107.67 | 10.80B | 5.51B | 494.70M | 386.40M | 4.84 |
Davita Inc Stock (DVA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-03-06 | Eingeleitet | Barclays | Equal Weight |
| 2023-08-07 | Hochstufung | UBS | Neutral → Buy |
| 2022-11-01 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2022-10-31 | Herabstufung | UBS | Buy → Neutral |
| 2022-08-19 | Fortgesetzt | UBS | Buy |
| 2022-06-21 | Bestätigt | BofA Securities | Underperform |
| 2021-09-10 | Eingeleitet | Cowen | Market Perform |
| 2021-08-12 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2021-03-26 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2021-01-05 | Herabstufung | BofA Securities | Buy → Neutral |
| 2020-01-24 | Hochstufung | Goldman | Neutral → Buy |
| 2019-11-07 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2019-10-25 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2019-09-11 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2019-07-26 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2019-01-08 | Hochstufung | UBS | Sell → Neutral |
| 2019-01-03 | Eingeleitet | Deutsche Bank | Buy |
| 2018-12-14 | Eingeleitet | Barclays | Overweight |
| 2018-11-28 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2018-11-16 | Eingeleitet | UBS | Sell |
| 2018-11-08 | Herabstufung | Raymond James | Strong Buy → Mkt Perform |
| 2018-09-13 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2018-01-04 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2017-12-12 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2017-12-11 | Hochstufung | Citigroup | Neutral → Buy |
| 2017-12-07 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2017-11-08 | Bestätigt | RBC Capital Mkts | Sector Perform |
| 2017-10-09 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2017-06-26 | Herabstufung | Jefferies | Buy → Hold |
| 2016-12-13 | Herabstufung | Robert W. Baird | Outperform → Neutral |
Alle ansehen
Davita Inc Aktie (DVA) Neueste Nachrichten
DaVita Inc. Stock Analysis and ForecastRapid growth trajectories - PrintWeekIndia
Inside Out: Analyzing Insider Selling at Davita and Its Implications for Investors - AInvest
Is DaVita Inc. a good long term investmentConsistently high yield - Autocar Professional
DaVita Inc chief compliance officer Hearty sells $352k in stock - Investing.com Nigeria
Insider Sell Alert: James Hearty Sells Shares of DaVita Inc (DVA) - GuruFocus
What analysts say about DaVita Inc. stockExplosive earning power - jammulinksnews.com
What drives DaVita Inc. stock priceSkyrocketing investment returns - Autocar Professional
How Investors May Respond To DaVita (DVA) Credit Agreement Amendment and $250M Loan Raise - simplywall.st
DaVita HealthCare (DVA) Stock Sinks As Market Gains: What You Should Know - Yahoo Finance
For Sale: DaVita Dialysis building in Willow Grove | $3,710,000 - Glenside Local
DaVita Inc. (DVA) Stock Analysis: Evaluating Growth Potential Amidst Strong ROE and Revenue Growth - DirectorsTalk Interviews
Lobbying Update: $90,000 of DAVITA INC. lobbying was just disclosed - Nasdaq
DaVita’s Quarterly Earnings Preview: What You Need to Know - MSN
DaVita Inc. Schedules 2nd Quarter 2025 Investor Conference Call - Kilgore News Herald
DaVita Amends Credit Agreement with $250M Loan - TipRanks
Allen learns about dialysis legislation - Statesboro Herald
DaVita Inc. (NYSE:DVA) Looks Inexpensive But Perhaps Not Attractive Enough - 富途牛牛
DaVita Inc. Q2 2025 Earnings Preview: What to ExpectNews and Statistics - IndexBox
DaVita’s Quarterly Earnings Preview: What You Need To Know - Barchart.com
DaVita Healthcare (DVA): Riding Out the Storm with Undervalued Potential - AInvest
DaVita HealthCare (DVA) Dips More Than Broader Market: What You Should Know - Yahoo Finance
What makes DaVita Inc. stock price move sharplyChart Breakout Alert - beatles.ru
DaVita Inc. (DVA) Stock Analysis: Unpacking the Impressive 54.79% Return on Equity and Its Implications for Investors - DirectorsTalk Interviews
DaVita's ESG Leadership: A Catalyst for Valuation Uplift in Healthcare - AInvest
DaVita Reveals Its Developments Towards ESG Goals in Its Community Care Report - Yahoo Finance
12 Best Stocks to Invest In for Good Returns - Insider Monkey
Finanzdaten der Davita Inc-Aktie (DVA)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.50%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):